ERBB2 and breast cancer: Of the 4 molecular subtypes of breast cancer—basal-like, luminal A, luminal B, and HER2 positive—the type most strongly associated with LSD-1 overexpression is basal-like breast cancer, which, as previously mentioned, is also more likely to occur in individuals carrying BRCA1 PV.